Suppr超能文献

透析中的磷控制

Phosphate control in dialysis.

作者信息

Cupisti Adamasco, Gallieni Maurizio, Rizzo Maria Antonietta, Caria Stefania, Meola Mario, Bolasco Piergiorgio

机构信息

Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.

出版信息

Int J Nephrol Renovasc Dis. 2013 Oct 4;6:193-205. doi: 10.2147/IJNRD.S35632.

Abstract

Prevention and correction of hyperphosphatemia is a major goal of chronic kidney disease-mineral and bone disorder (CKD-MBD) management, achievable through avoidance of a positive phosphate balance. To this aim, optimal dialysis removal, careful use of phosphate binders, and dietary phosphate control are needed to optimize the control of phosphate balance in well-nourished patients on a standard three-times-a-week hemodialysis schedule. Using a mixed diffusive-convective hemodialysis tecniques, and increasing the number and/or the duration of dialysis tecniques are all measures able to enhance phosphorus (P) mass removal through dialysis. However, dialytic removal does not equal the high P intake linked to the high dietary protein requirement of dialysis patients; hence, the use of intestinal P binders is mandatory to reduce P net intestinal absorption. Unfortunately, even a large dose of P binders is able to bind approximately 200-300 mg of P on a daily basis, so it is evident that their efficacy is limited in the case of an uncontrolled dietary P load. Hence, limitation of dietary P intake is needed to reach the goal of neutral phosphate balance in dialysis, coupled to an adequate protein intake. To this aim, patients should be informed and educated to avoid foods that are naturally rich in phosphate and also processed food with P-containing preservatives. In addition, patients should preferentially choose food with a low P-to-protein ratio. For example, patients could choose egg white or protein from a vegetable source. Finally, boiling should be the preferred cooking procedure, because it induces food demineralization, including phosphate loss. The integrated approach outlined in this article should be actively adapted as a therapeutic alliance by clinicians, dieticians, and patients for an effective control of phosphate balance in dialysis patients.

摘要

预防和纠正高磷血症是慢性肾脏病 - 矿物质和骨异常(CKD - MBD)管理的主要目标,可通过避免磷的正平衡来实现。为此,对于接受标准每周三次血液透析的营养良好的患者,需要优化透析清除、谨慎使用磷结合剂以及控制饮食中的磷,以优化磷平衡的控制。采用混合扩散 - 对流血液透析技术、增加透析次数和/或延长透析时间,都是能够增强通过透析清除磷质量的措施。然而,透析清除量并不等同于与透析患者高膳食蛋白质需求相关的高磷摄入量;因此,必须使用肠道磷结合剂来减少肠道磷的净吸收。不幸的是,即使大剂量的磷结合剂每天也只能结合约200 - 300毫克的磷,所以很明显,在饮食中磷负荷不受控制的情况下,它们的疗效是有限的。因此,需要限制饮食中的磷摄入量,以实现透析中磷平衡的目标,同时保证足够的蛋白质摄入量。为此,应告知并教育患者避免食用天然富含磷的食物以及含有含磷防腐剂的加工食品。此外,患者应优先选择磷与蛋白质比例低的食物。例如,患者可以选择蛋清或植物来源的蛋白质。最后,煮沸应是首选的烹饪方法,因为它会使食物脱矿质化,包括磷的流失。本文概述的综合方法应由临床医生、营养师和患者积极作为一种治疗联盟加以采用,以有效控制透析患者的磷平衡。

相似文献

1
Phosphate control in dialysis.
Int J Nephrol Renovasc Dis. 2013 Oct 4;6:193-205. doi: 10.2147/IJNRD.S35632.
3
Intensive Hemodialysis, Mineral and Bone Disorder, and Phosphate Binder Use.
Am J Kidney Dis. 2016 Nov;68(5S1):S24-S32. doi: 10.1053/j.ajkd.2016.05.024.
4
5
Dietary Phosphate and the Forgotten Kidney Patient: A Critical Need for FDA Regulatory Action.
Am J Kidney Dis. 2019 Apr;73(4):542-551. doi: 10.1053/j.ajkd.2018.11.004. Epub 2019 Jan 25.
9
Derangements in phosphate metabolism in chronic kidney diseases/endstage renal disease: therapeutic considerations.
Adv Chronic Kidney Dis. 2011 Mar;18(2):120-31. doi: 10.1053/j.ackd.2011.02.004.
10
Management of natural and added dietary phosphorus burden in kidney disease.
Semin Nephrol. 2013 Mar;33(2):180-90. doi: 10.1016/j.semnephrol.2012.12.018.

引用本文的文献

3
OSTEOPROTEGERIN AS AN EARLY SIGN OF CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER.
Acta Clin Croat. 2023 Jul;62(Suppl2):46-52. doi: 10.20471/acc.2023.62.s2.7.
8
Kinetically Inert Macrocyclic Europium(III) Receptors for Phosphate.
Inorg Chem. 2023 Jul 3;62(26):10064-10076. doi: 10.1021/acs.inorgchem.2c03833. Epub 2023 Jun 20.
10
Mineral Bone Disorders in Kidney Disease Patients: The Ever-Current Topic.
Int J Mol Sci. 2022 Oct 13;23(20):12223. doi: 10.3390/ijms232012223.

本文引用的文献

2
Management of natural and added dietary phosphorus burden in kidney disease.
Semin Nephrol. 2013 Mar;33(2):180-90. doi: 10.1016/j.semnephrol.2012.12.018.
4
High-efficiency postdilution online hemodiafiltration reduces all-cause mortality in hemodialysis patients.
J Am Soc Nephrol. 2013 Feb;24(3):487-97. doi: 10.1681/ASN.2012080875. Epub 2013 Feb 14.
5
Haemodiafiltration: becoming the new standard?
Nephrol Dial Transplant. 2013 Jan;28(1):1-2. doi: 10.1093/ndt/gfs542.
6
Sevelamer for hyperphosphataemia in kidney failure: controversy and perspective.
Ther Adv Chronic Dis. 2012 Mar;3(2):59-68. doi: 10.1177/2040622311433771.
8
Efficacy comparison between simple mixed-dilution and simple mid-dilution on-line hemodiafiltration techniques: a crossover study.
Artif Organs. 2012 Dec;36(12):1059-65. doi: 10.1111/j.1525-1594.2012.01508.x. Epub 2012 Aug 10.
9
Prevalence and progression of cardiovascular calcifications in peritoneal dialysis patients: A prospective study.
Bone. 2012 Sep;51(3):332-7. doi: 10.1016/j.bone.2012.06.002. Epub 2012 Jun 12.
10
Phosphate control in peritoneal dialysis.
Contrib Nephrol. 2012;178:116-123. doi: 10.1159/000337831. Epub 2012 May 25.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验